James McCormack is a Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia, Vancouver, Canada, and is passionate about music and evidence based medicine. In a unique endeavor that reminds me of the incomparable ZDoggMD, he has brought together these two passions in a synergistic manner. He has started making videos to promote the concepts of EBM amongst the common man, … Continue reading Viva la Evidence: EBM + ColdPlay
Happy Pumpkin Day folks, and to celebrate this day of weird encounters, I am going to reel off a list of the commonest peeves I have experienced in the past couple of years I have been doing Medicine. There are obvious gaps in the stories, and many are not even unique to me, but I must say, the more you read stuff and go “Its … Continue reading Trick or Treatment: Do Doctors Encourage Poor Patient Behaviors?
Why this Journal Club? Three simple reasons.. To provide students with an opportunity to critically read literature outside their key area of study: To provide students with an opportunity to critically discuss scientific papers. To sensitize them to EBM. Okay. So this is how it goes… A clinical scenario asking a question on the potential management of the case will be posted on the 1st … Continue reading Cochrane Students’ Journal Club: An Introduction
The conventional wisdom states that the intake of thyroid hormone replacement is best when done in the morning, on an empty stomach, in order to allow the best absorption and a more predictable range of serum concentration, thereby preventing potentially iatrogenic hypothyroidism. Now, this has also been studied, albeit in small groups (1), showing that Nonfasting regimens of levothyroxine administration are associated with higher and … Continue reading Timing the Tab-late
Clinical Evidence has an update on the management of Crohn’s disease. A very useful read considering the fact that it is a disease with rising number of cases. Here is a list of the recommendations which underwent changes: Aminosalicylates to maintain remission: Categorization changed from likely to be ineffective/harmful to likely to ber beneficial Fish Oil: Categorization unchanged to Unknown efficacy Treatments which are listed under … Continue reading Crohn’s Disease on Clinical Evidence, BMJ
